Evaluation of the MammaTyperVR as a molecular predictor for pathological complete response (pCR) after neoadjuvant chemotherapy (NACT) and outcome in patients with different breast cancer (BC) subtypes
Fasching P, Laible M, Weber KE, Wirtz RM, Denkert C, Schlombs K, Schmatloch S, Camara O, Lueck HJ, Huober J, Karn T, Van Mackelenbergh MT, Marme F, Mueller V, Schem C, Stickeler E, Sahin U, Loibl S, Untch M (2018)
Publication Type: Conference contribution
Publication year: 2018
Journal
Publisher: OXFORD UNIV PRESS
City/Town: OXFORD
Pages Range: 73-73
Conference Proceedings Title: ANNALS OF ONCOLOGY
Event location: Munich
DOI: 10.1093/annonc/mdy270.222
Authors with CRIS profile
Involved external institutions
Universitätsklinikum Hamburg-Eppendorf (UKE)
Germany (DE)
HELIOS Kliniken
Germany (DE)
Universitätsklinikum Aachen (UKA)
Germany (DE)
Universitätsklinikum Ulm
Germany (DE)
BioNTech / Biopharmaceutical New Technologies
Germany (DE)
STRATIFYER Molecular Pathology GmbH
Germany (DE)
GBG Forschungs GmbH (German Breast Group)
Germany (DE)
Nationales Centrum für Tumorerkrankungen (NCT) Heidelberg
Germany (DE)
Charité - Universitätsmedizin Berlin
Germany (DE)
Universitätsklinikum Frankfurt am Main (KGU)
Germany (DE)
Krankenhaus Jerusalem
Germany (DE)
Elisabeth-Krankenhaus Essen
Germany (DE)
Hufeland Klinikum
Germany (DE)
Universitätsklinikum Schleswig-Holstein (UKSH)
Germany (DE)
Germany (DE)
HELIOS Kliniken
Germany (DE)
Universitätsklinikum Aachen (UKA)
Germany (DE)
Universitätsklinikum Ulm
Germany (DE)
BioNTech / Biopharmaceutical New Technologies
Germany (DE)
STRATIFYER Molecular Pathology GmbH
Germany (DE)
GBG Forschungs GmbH (German Breast Group)
Germany (DE)
Nationales Centrum für Tumorerkrankungen (NCT) Heidelberg
Germany (DE)
Charité - Universitätsmedizin Berlin
Germany (DE)
Universitätsklinikum Frankfurt am Main (KGU)
Germany (DE)
Krankenhaus Jerusalem
Germany (DE)
Elisabeth-Krankenhaus Essen
Germany (DE)
Hufeland Klinikum
Germany (DE)
Universitätsklinikum Schleswig-Holstein (UKSH)
Germany (DE)
How to cite
APA:
Fasching, P., Laible, M., Weber, K.E., Wirtz, R.M., Denkert, C., Schlombs, K.,... Untch, M. (2018). Evaluation of the MammaTyperVR as a molecular predictor for pathological complete response (pCR) after neoadjuvant chemotherapy (NACT) and outcome in patients with different breast cancer (BC) subtypes. In ANNALS OF ONCOLOGY (pp. 73-73). Munich, DE: OXFORD: OXFORD UNIV PRESS.
MLA:
Fasching, Peter, et al. "Evaluation of the MammaTyperVR as a molecular predictor for pathological complete response (pCR) after neoadjuvant chemotherapy (NACT) and outcome in patients with different breast cancer (BC) subtypes." Proceedings of the 43rd ESMO Congress (ESMO), Munich OXFORD: OXFORD UNIV PRESS, 2018. 73-73.
BibTeX: Download